Form 4 Tracker
Harmony Biosciences Holdings, Inc.
HRMY

20 insider filings · Latest: Sep 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 21, 2025Jan 21 9:21 PMJEFFREY M DAYNO
Proposed Sale
19,293$39.05$753.4K—

View →

Jan 21, 2025Jan 21 9:20 PMJEFFREY G DIERKS
Proposed Sale
1,123$39.05$43.9K—

View →

Jan 13, 2025Jan 13 9:26 PMJEFFREY G DIERKS
Proposed Sale
47,162$33.86$1.6M—

View →

Oct 29, 2024Oct 29 8:22 PMJEFFREY G DIERKS
Proposed Sale
21,496$35.75$768.5K—

View →

Oct 3, 2024Oct 3 8:32 PMJEFFREY G DIERKS
Proposed Sale
14,961$35.57$532.2K—

View →

Oct 1, 2024Oct 1 8:35 PMJEFFREY G DIERKS
Proposed Sale
21,796$40.00$871.8K—

View →

Sep 30, 2024Sep 30 8:28 PMJEFFREY G DIERKS
Proposed Sale
7,175$39.13$280.8K—

View →

Sep 27, 2024Sep 27 8:24 PMJEFFREY G DIERKS
Proposed Sale
28,971$39.79$1.2M—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 22, 2026Jan 26 9:48 PMAndrew SerafinCHIEF STRATEGY OFFICER
Grant/Award
54,800$36.7612,200(D)

View →

Jan 25, 2026Jan 26 9:45 PMKumar BudurCHIEF MEDICAL OFFICER
Option Exercise
2,662—7,988(D)

View →

Jan 24, 2026Jan 26 9:45 PMKumar BudurCHIEF MEDICAL OFFICER
Option Exercise
2,188—4,175(D)

View →

Jan 22, 2026Jan 26 9:45 PMKumar BudurCHIEF MEDICAL OFFICER
Grant/Award
54,800$36.7612,200(D)

View →

Jan 22, 2026Jan 26 9:44 PMAdam H. ZaeskeCHIEF COMMERCIAL OFFICER
Grant/Award
73,100$36.7616,200(D)

View →

Jan 25, 2026Jan 26 9:43 PMJeffrey M. DaynoDirector, PRESIDENT, CEO
Option Exercise
13,000—39,000(D)

View →

Jan 24, 2026Jan 26 9:43 PMJeffrey M. DaynoDirector, PRESIDENT, CEO
Option Exercise
10,500—21,000(D)

View →

Jan 22, 2026Jan 26 9:43 PMJeffrey M. DaynoDirector, PRESIDENT, CEO
Grant/Award
237,500$36.7652,900(D)

View →

← Previous

Page 2 of 2